Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mohammad Azab Insider Profile
4 Followers
Mohammad Azab, Director at Xenon, holds 58.68K shares in Lisata Therapeutics (Ticker: LSTA), holds 74.22K shares in Xenon (Ticker: XENE), holds 60.00K shares in Durect (Ticker: DRRX).
Profitable Transactions
5 out of 8 Profitable Transactions
Average Return
+118.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Mohammad Azab holds in companies
Most Profitable Insider Trade
The most profitable trade made by Mohammad Azab
Mohammad Azab's Trading History
Xenon
Dec 20, 2023
Director
Uninformative Buy
42.55K
$2.87M
Durect
May 25, 2022
Director
Informative Buy
11.45K
$57.00K
Lisata Therapeutics
Jan 11, 2024
Director
Uninformative Buy
―
$159.02K
Novelion Therapeutics
―
―
―
$842.40
Astex Pharmaceuticals
―
―
―
―
List of latest transactions for each holding click on a transaction to see Mohammad Azab's performance on stock
You May Also Like
Mohammad Azab insider profile FAQ
What is the percentage of profitable transactions made by Mohammad Azab?
The percentage of profitable transactions made by Mohammad Azab is 63%.
What is the average return per transaction made by Mohammad Azab?
The average return per transaction made by Mohammad Azab is 118.50%.
What stocks does Mohammad Azab hold?
Mohammad Azab holds: XENE, DRRX, LSTA, NVLNF, ASTX stocks.
What was Mohammad Azab’s latest transaction?
Mohammad Azab latest transaction was an Uninformative Buy of ―.
What was Mohammad Azab's most profitable transaction?
Mohammad Azab’s most profitable transaction was an Informative Buy of XENE stock on September 25, 2017. The return on the trade was 352.90%.
What is Mohammad Azab's role in Xenon?
Mohammad Azab's role in Xenon is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.